SCHEMBL1401028

SCHEMBL1401028

CC(C)C(=O)NC(N)=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11813607 0.85 TAS2R38 (0.48)
SCHEMBL10394961 0.78 TAS2R38 (0.46)
SCHEMBL9428999 0.78
SCHEMBL13285717 0.77 TAS2R38 (0.44)
SCHEMBL2775 0.76 GAA (0.37)
SCHEMBL13860758 0.76 ALDH1A1 (0.42)
SCHEMBL13861720 0.76
SCHEMBL5696107 0.74
SCHEMBL22856648 0.72 CRBN (0.36)
SCHEMBL28347670 0.71 GAA (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120574189-A Improved efficient preparation method of peptide amiloride 三峡大学 2025-09-02 CN disclosed
CN-115702148-B Process for the manufacture of alkylamide thiazoles 帝斯曼知识产权资产管理有限公司 2024-09-06 CN disclosed
EP-4165029-B1 PROCESS FOR THE MANUFACTURE OF ALKYLAMIDOTHIAZOLES DSM IP ASSETS BV (NL) 2024-07-17 EP disclosed
US-20230312495-A1 NEW ISOBUTYRAMIDE DERIVATIVES, COSMETIC AND/OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID COMPOUNDS, AND THEIR USE FOR THE PROPHYLAXIS AND TREATMENT OF SENSITIVE, IN PARTICULAR INFLAMED SKIN OR INFLAMMATORY SKIN CONDITIONS BEIERSDORF AG (DE) 2023-10-05 US disclosed
US-20230312495-A1 NEW ISOBUTYRAMIDE DERIVATIVES, COSMETIC AND/OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID COMPOUNDS, AND THEIR USE FOR THE PROPHYLAXIS AND TREATMENT OF SENSITIVE, IN PARTICULAR INFLAMED SKIN OR INFLAMMATORY SKIN CONDITIONS BEIERSDORF AG (DE) 2023-10-05 US disclosed
EP-4165029-A1 PROCESS FOR THE MANUFACTURE OF ALKYLAMIDOTHIAZOLES DSM IP Assets B.V. (NL) 2023-04-19 EP disclosed
CN-115702148-A Process for the manufacture of alkylamide thiazoles 帝斯曼知识产权资产管理有限公司 2023-02-14 CN disclosed
WO-2022037927-A1 NEW ISOBUTYRYAMIDE DERIVATIVES, COSMETIC AND/OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID COMPOUNDS, AND THEIR USE FOR THE PROPHYLAXIS AND TREATMENT OF SENSIBLE, IN PARTICULAR INFLAMED SKIN OR INFLAMMATORY SKIN CONDITIONS BEIERSDORF AG (DE) 2022-02-24 WO disclosed
WO-2021255011-A1 PROCESS FOR THE MANUFACTURE OF ALKYLAMIDOTHIAZOLES DSM IP ASSETS B.V. (NL) 2021-12-23 WO disclosed
EP-2969027-B1 COMPOSITIONS OF ALKYLAMIDOTHIAZOLES AND FRAGRANCES BEIERSDORF AG (DE) 2020-10-14 EP disclosed
US-20070243166-A1 Hepatitis C Inhibitor Compounds LLINAS-BRUNET MONTSE 2007-10-18 US disclosed
US-20070243166-A1 Hepatitis C Inhibitor Compounds LLINAS-BRUNET MONTSE 2007-10-18 US disclosed
CN-1856502-A Macrocyclic peptides active against hepatitis C virus BOEHRINGER INGELHEIM INT (DE) 2006-11-01 CN disclosed
EP-1673385-A4 MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS BOEHRINGER INGELHEIM INT (DE) 2006-10-04 EP disclosed
EP-1673385-A1 MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS Boehringer Ingelheim International GmbH (DE) 2006-06-28 EP disclosed
US-20050080005-A1 Macrocyclic peptides active against the hepatitis C virus BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-04-14 US disclosed
WO-2005028501-A1 MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-03-31 WO disclosed
WO-2005028501-A1 MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-03-31 WO disclosed
US-4243407-A 2-Acylaminothiazol-4-ylacetamides as post emergent selective herbicides GULF OIL CORPORATION (US) 1981-01-06 US disclosed
US-4232163-A 2-Acylaminothiazol-4-ylacetamides as post emergent selective herbicides GULF OIL CORPORATION (US) 1980-11-04 US disclosed